학술논문
PND35 - Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain
Document Type
Abstract
Author
Source
In Value in Health October-November 2017 20(9):A723-A723
Subject
Language
ISSN
1098-3015